Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-11-20

Clinical Trial Update: Aspirin as a Pre-Treatment for Exercise in Multiple Sclerosis [EARLY_Phase 1]

View source ↗

Summary

Early phase 1 trial investigating aspirin as a pre-treatment to exercise in individuals with fatigue-related symptoms in multiple sclerosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Aspirin (Aspirin)

Snippet

Sponsor: Columbia University | Conditions: Fatigue, Overheating | EARLY_Phase 1 | Status: COMPLETED | Results posted: 2018-11-20